Form D Explorer

Source evidence

Trace Biosciences Inc. · 0002147501-26-000002

D filed Aug. 12, 2026. Extracted source facts are preserved separately from the current issuer profile and normalized display values.

SEC filing indexDownload stored sourceReport a record issue

Explicit source references

These accession references come from the source document. They describe a reported link; they do not establish new financing or an independently verified offering group.

Identity as reported in this document

city
BEAVERTON
street1
1800 NW 167TH PL
street2
STE 160
zipCode
97006
entityName
Trace Biosciences Inc.
entityType
Corporation
stateOrCountry
Oregon
jurisdictionOfInc
DELAWARE
Individual source fields, including raw text and value state
FieldRaw sourceStateParsed valueSource location
Reported finders fees0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/findersFees/dollarAmount
Reported amount sold8334499number8334499/edgarSubmission/offeringData/offeringSalesAmounts/totalAmountSold
Reported sales commissions0number0/edgarSubmission/offeringData/salesCommissionsFindersFees/salesCommissions/dollarAmount
Reported offering amount16234498number16234498/edgarSubmission/offeringData/offeringSalesAmounts/totalOfferingAmount
Reported minimum investment0number0/edgarSubmission/offeringData/minimumInvestmentAccepted
Reported investor count19number19/edgarSubmission/offeringData/investors/totalNumberAlreadyInvested

Document SHA-256: 6455f4521cb3c791012072059a1751d4bfe3b28268abfc9d4053a62f38ae5710. This proves extraction identity, not the accuracy of the filer's claims.